⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29848157 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL28985148 | 0.98 | CYP11B2 (0.77) | — | |
| Cyanide SCHEMBL28041112 | 0.94 | CYP11B2 (0.71) | — | |
| Formaldehyde SCHEMBL28570916 | 0.94 | CYP11B2 (0.71) | — | |
| SCHEMBL6095783 | 0.91 | CYP11B2 (0.96) | — | |
| SCHEMBL26154135 | 0.91 | CYP11B2 (0.88) | — | |
| SCHEMBL30434052 | 0.91 | CYP11B2 (0.88) | — | |
| SCHEMBL24034677 | 0.90 | CYP11B2 (0.67) | — | |
| SCHEMBL1722639 | 0.90 | CYP11B2 (0.67) | — | |
| SCHEMBL13153725 | 0.90 | CYP11B2 (0.67) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000692-A1 | Substituted N-(Pyridin-2-yl)Acetamide Derivatives as CDK12/13 Inhibitors | AURIGENE ONCOLOGY LIMITED (IN) | 2026-01-01 | — | — | US | claimed |
| WO-2022101265-A1 | PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2022-05-19 | — | — | WO | claimed |
| EP-3363788-A1 | CANNABINOID RECEPTOR MODULATORS | Arena Pharmaceuticals, Inc. (US) | 2018-08-22 | — | — | EP | claimed |
| CN-104507910-B | Partially saturated nitrogen-containing heterocyclic compound | 大正制药株式会社 | 2016-06-15 | — | — | CN | claimed |
| US-20130165412-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2013-06-27 | — | — | US | claimed |
| US-20120214766-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2012-08-23 | — | — | US | claimed |
| EP-2470508-A1 | CANNABINOID RECEPTOR MODULATORS | Arena Pharmaceuticals, Inc. (US) | 2012-07-04 | — | — | EP | claimed |
| WO-2011025541-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. (US) | 2011-03-03 | — | — | WO | claimed |
| CN-101678011-A | Spiro-indolinone compounds | MERCK & CO INC | 2010-03-24 | — | — | CN | claimed |
| US-7442691-B2 | Macrocycles useful in the treatment of alzheimer's disease | PHARMACIA & UPJOHN COMPANY (US) | 2008-10-28 | — | — | US | claimed |
| EP-1404671-B1 | MACROCYCLES USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | ELAN PHARM INC (US) | 2006-04-12 | — | — | EP | claimed |
| US-20060040910-A1 | Macrocycles useful in the treatment of Alzheimer's disease | PHARMACIA & UPJOHN COMPANY LLC | 2006-02-23 | — | — | US | claimed |
| US-6969709-B2 | Macrocycles useful in the treatment of Alzheimer's disease | PHARMACIA & UPJOHN COMPANY (US) | 2005-11-29 | — | — | US | claimed |
| EP-1404671-A1 | MACROCYCLES USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-04-07 | — | — | EP | claimed |
| US-20030236199-A1 | Mycrocycles useful in the teatment of Alzheimer's disease | PHARMACIA & UPJOHN COMPANY | 2003-12-25 | — | — | US | claimed |
| WO-2002100856-A1 | MACROCYCLES USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | claimed |
| US-20260021085-A1 | CYCLOALKYL CARBOXYLIC ACID DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF | MAZE THERAPEUTICS INC (US) | 2026-01-22 | — | — | US | disclosed |
| EP-4643644-A2 | PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS | Syngenta Crop Protection AG (CH) | 2025-11-05 | — | — | EP | disclosed |
| WO-2007071358-A1 | NICOTINIC ACID DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | NOVARTIS AG (CH) | 2007-06-28 | — | — | WO | disclosed |
| EP-1790650-A1 | NOVEL SUBSTITUTED IMIDAZOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-05-30 | — | — | EP | disclosed |